Citigroup’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17M | Buy |
421,067
+386,938
| +1,134% | +$14.5M | 0.01% | 1163 |
|
|
2025
Q4 | $1.19M | Sell |
34,129
-41,383
| -55% | -$3.25M | ﹤0.01% | 3023 |
|
|
2025
Q3 | $6.28M | Sell |
75,512
-21,739
| -22% | -$1.57M | ﹤0.01% | 1818 |
|
|
2025
Q2 | $7.14M | Sell |
97,251
-62,909
| -39% | -$4.56M | ﹤0.01% | 1618 |
|
|
2025
Q1 | $18.3M | Buy |
160,160
+15,915
| +11% | +$969K | 0.01% | 1023 |
|
|
2024
Q4 | $7.27M | Sell |
144,245
-461
| -0.3% | -$24.2K | ﹤0.01% | 1625 |
|
|
2024
Q3 | $6.7M | Buy |
144,706
+48,270
| +50% | +$1.72M | ﹤0.01% | 1609 |
|
|
2024
Q2 | $3.13M | Sell |
96,436
-10,515
| -10% | -$288K | ﹤0.01% | 1987 |
|
|
2024
Q1 | $2.69M | Buy |
106,951
+28,079
| +36% | +$663K | ﹤0.01% | 2189 |
|
|
2023
Q4 | $2.56M | Buy |
78,872
+27,054
| +52% | +$743K | ﹤0.01% | 2038 |
|
|
2023
Q3 | $1.41M | Sell |
51,818
-35,116
| -40% | -$1.02M | ﹤0.01% | 2250 |
|
|
2023
Q2 | $1.93M | Buy |
86,934
+14,248
| +20% | +$328K | ﹤0.01% | 2248 |
|
|
2023
Q1 | $1.57M | Sell |
72,686
-2,072
| -3% | -$45.4K | ﹤0.01% | 2188 |
|
|
2022
Q4 | $1.52M | Buy |
74,758
+3,823
| +5% | +$95.8K | ﹤0.01% | 2259 |
|
|
2022
Q3 | $1.82M | Buy |
70,935
+2,168
| +3% | +$58K | ﹤0.01% | 2215 |
|
|
2022
Q2 | $1.64M | Sell |
68,767
-34,474
| -33% | -$751K | ﹤0.01% | 2258 |
|
|
2022
Q1 | $2.33M | Buy |
103,241
+13,488
| +15% | +$287K | ﹤0.01% | 2246 |
|
|
2021
Q4 | $1.78M | Buy |
89,753
+2,396
| +3% | +$48.6K | ﹤0.01% | 2726 |
|
|
2021
Q3 | $1.72M | Sell |
87,357
-964
| -1% | -$20.2K | ﹤0.01% | 2661 |
|
|
2021
Q2 | $1.94M | Buy |
88,321
+48,373
| +121% | +$1.08M | ﹤0.01% | 2689 |
|
|
2021
Q1 | $950K | Sell |
39,948
-15,978
| -29% | -$427K | ﹤0.01% | 3023 |
|
|
2020
Q4 | $1.46M | Sell |
55,926
-30,200
| -35% | -$636K | ﹤0.01% | 3158 |
|
|
2020
Q3 | $1.5M | Sell |
86,126
-36,624
| -30% | -$584K | ﹤0.01% | 2923 |
|
|
2020
Q2 | $2.06M | Buy |
122,750
+29,642
| +32% | +$416K | ﹤0.01% | 2776 |
|
|
2020
Q1 | $1.11M | Sell |
93,108
-14,582
| -14% | -$180K | ﹤0.01% | 3064 |
|
|
2019
Q4 | $1.3M | Sell |
107,690
-32,144
| -23% | -$447K | ﹤0.01% | 3478 |
|
|
2019
Q3 | $1.98M | Buy |
139,834
+49,335
| +55% | +$606K | ﹤0.01% | 2881 |
|
|
2019
Q2 | $1.01M | Sell |
90,499
-39,596
| -30% | -$441K | ﹤0.01% | 3620 |
|
|
2019
Q1 | $1.53M | Sell |
130,095
-80,198
| -38% | -$997K | ﹤0.01% | 2956 |
|
|
2018
Q4 | $2.81M | Buy |
210,293
+104,784
| +99% | +$1.38M | ﹤0.01% | 2348 |
|
|
2018
Q3 | $1.48M | Sell |
105,509
-100,526
| -49% | -$1.4M | ﹤0.01% | 3059 |
|
|
2018
Q2 | $3.24M | Buy |
206,035
+159,380
| +342% | +$2.77M | ﹤0.01% | 2235 |
|
|
2018
Q1 | $767K | Sell |
46,655
-202,837
| -81% | -$3.76M | ﹤0.01% | 3520 |
|
|
2017
Q4 | $4.51M | Buy |
249,492
+4,674
| +2% | +$84.7K | ﹤0.01% | 1929 |
|
|
2017
Q3 | $4.72M | Buy |
244,818
+69,604
| +40% | +$1.04M | ﹤0.01% | 1825 |
|
|
2017
Q2 | $2.07M | Buy |
175,214
+148,918
| +566% | +$1.62M | ﹤0.01% | 2559 |
|
|
2017
Q1 | $288K | Sell |
26,296
-49,367
| -65% | -$434K | ﹤0.01% | 4340 |
|
|
2016
Q4 | $549K | Buy |
75,663
+49,690
| +191% | +$389K | ﹤0.01% | 4276 |
|
|
2016
Q3 | $169K | Buy |
25,973
+9,990
| +63% | +$58.1K | ﹤0.01% | 4791 |
|
|
2016
Q2 | $88K | Sell |
15,983
-38,756
| -71% | -$202K | ﹤0.01% | 5179 |
|
|
2016
Q1 | $256K | Buy |
54,739
+25,467
| +87% | +$99.2K | ﹤0.01% | 4848 |
|
|
2015
Q4 | $146K | Buy |
29,272
+29,262
| +292,620% | +$132K | ﹤0.01% | 5032 |
|
|
2015
Q3 | $0 | Sell |
10
-794
| -99% | -$4.03K | ﹤0.01% | 7415 |
|
|
2015
Q2 | $5K | Sell |
804
-4,374
| -84% | -$26.8K | ﹤0.01% | 6733 |
|
|
2015
Q1 | $29K | Sell |
5,178
-3,978
| -43% | -$14.4K | ﹤0.01% | 5854 |
|
|
2014
Q4 | $27K | Buy |
9,156
+7,301
| +394% | +$22.3K | ﹤0.01% | 6066 |
|
|
2014
Q3 | $5K | Buy |
1,855
+904
| +95% | +$2.39K | ﹤0.01% | 6549 |
|
|
2014
Q2 | $3K | Sell |
951
-7,805
| -89% | -$23K | ﹤0.01% | 6612 |
|
|
2014
Q1 | $38K | Sell |
8,756
-7,919
| -47% | -$27.7K | ﹤0.01% | 5661 |
|
|
2013
Q4 | $54K | Buy |
16,675
+16,604
| +23,386% | +$33.6K | ﹤0.01% | 5673 |
|
|
2013
Q3 | $0 | Buy |
71
+1
| +1% | +$2 | ﹤0.01% | 6811 |
|
|
2013
Q2 | $0 | Buy |
+70
| New | +$126 | ﹤0.01% | 6744 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
Citigroup's CORT Position: Q1 2026 in Review
Citigroup increased its Corcept Therapeutics (CORT) stake by 1,134% in Q1 2026, buying an estimated $14.5M and bringing the position to 421,067 shares worth $17M. The position accounts for 0.01% of the portfolio, ranked #1163.
Citigroup first reported a position in CORT in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.3M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Citigroup held 421,067 shares of Corcept Therapeutics worth $17M as of Q1 2026.
- Citigroup bought 386,938 Corcept Therapeutics shares in Q1 2026, an estimated $14.5M.
- Corcept Therapeutics made up 0.01% of Citigroup's portfolio in Q1 2026, its #1163 holding.
- Citigroup first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Corcept Therapeutics position peaked at $18.3M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.